TY - JOUR T1 - Exploration the Standard diagnosis and treatment in Patients with Type 2 Diabetes in a tertiary first-class hospital in Fujian Province JF - medRxiv DO - 10.1101/2020.03.06.20026591 SP - 2020.03.06.20026591 AU - Xiaoyan Lin AU - Wei Lin AU - Junping Wen AU - Gang Chen Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/03/10/2020.03.06.20026591.abstract N2 - Objective The aim of this study was to evaluate the knowledge and clinical practice of ‘‘guideline for prevention and treatment of Type 2 diabetes in China’’ among the physicians. We took a tertiary first-class hospital in Fujian Province as an example to identify the differences between clinical practice and guideline.Methods We selected 3000 inpatients with type 2 diabetes who visited at the tertiary first-class hospital in Fujian Province between September 2017 to November 2017, then retrospectively analyzed their clinical data, including age, gender, height, weight, body mess index, admission departments, combined diseases, complications, course of disease, diabetes diet education, monitoring of blood glucose and blood pressure, the selection of hypoglycemic therapy and other secondary prevention measures. The data we obtained was analyzed by SPSS 19.0 software.Results A total of 3000 effective inpatient were enrolled, including 1724 male and 1276 female, the mean age(± standard deviation) of patients was 66.21 ± 11.75 years, the mean hospitalization days was 12.26±10.30 days.In this study, we found that:1.only 60.9% of the patients have monitored HbA1C in nearly 3 months; in the last year, 96.3% of patients have monitored blood lipid;98.1% of patients have monitored the serum creatinine;only 9.5% of patients have received comprehensive eye examination by an ophthalmologist or optometrist.2.After admission, 73.3% of patients have received the education about diabetes diet; 86.8% of patients have accepted the peripheral blood glucose monitoring;among 2084 diabetic patients combined with hypertension, only 1868 patients (89.6%) have received blood pressure monitoring.3. Among 202 patients who are newly diagnosed diabetes, there were 45 cases meet HbA1C > 9.0% or FPG > 11.1 mmol/ L, only 25 people (55.56%) have received an intensive insulin therapy.4.Among 474 patients who have undergone an large or medium-sized surgical treatment, about 182(62.1%) patients have started a hypoglycemic therapy before the operation, and only 196(41.4%) patients have changed into intensive insulin therapy before surgery.5. About 714 of diabetic patients who combined with a clear history of cardiovascular, only 548 (76.8%) patients have received antiplatelet therapy;and 566 people (79.3%) have used statin to lower blood lipid. 6.In total, only 168(5.6%) patients have received a relatively standard diagnosis and treatment in non-surgical department, and only 4(0.1%) patients in surgical department.Conclusion There are still many deficiencies in clinical practice of type 2 diabetes guideline, even in tertiary first-class hospital, there are also many physicians, especially non-specialist doctors, were not familiar with the knowledge of guideline for management of Type 2 diabetes.The acute exacerbation of diabetes in the global can take serious complications and bring heavy economic burden, so it required us to pay attention to the prevention and early treatment of diabetes. We suggest to popularize the “guideline for management of Type 2 diabetes” through various forms, such as academic seminars, lecture tour and medical staffs, so as to enhance the education of physicians and promote treatment based on guideline of type 2 diabetes.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yesall data included in this study are available upon request by contact with the corresponding author. ER -